The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharma & Cosmetics-Global Market Insights and Sales Trends 2024
Synopsis
The global Biopharma & Cosmetics market size is expected to reach US$ 2372950 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma & Cosmetics in various end use industries. The expanding demands from the Pharmaceuticals, OTC and Cosmetics, are propelling Biopharma & Cosmetics market. Ointments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Creams segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma & Cosmetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma & Cosmetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma & Cosmetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma & Cosmetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma & Cosmetics covered in this report include Johnson & Johnson, Roche, Novartis, Pfizer, Sanofi, Eli Lilly, GSK, Bayer and Merck & Co, etc.
The global Biopharma & Cosmetics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Global Biopharma & Cosmetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma & Cosmetics market, Segment by Type:
Ointments
Creams
Gel
Others
Global Biopharma & Cosmetics market, by Application
Pharmaceuticals, OTC
Cosmetics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma & Cosmetics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biopharma & Cosmetics market size is expected to reach US$ 2372950 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma & Cosmetics in various end use industries. The expanding demands from the Pharmaceuticals, OTC and Cosmetics, are propelling Biopharma & Cosmetics market. Ointments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Creams segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma & Cosmetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma & Cosmetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma & Cosmetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma & Cosmetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma & Cosmetics covered in this report include Johnson & Johnson, Roche, Novartis, Pfizer, Sanofi, Eli Lilly, GSK, Bayer and Merck & Co, etc.
The global Biopharma & Cosmetics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Global Biopharma & Cosmetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma & Cosmetics market, Segment by Type:
Ointments
Creams
Gel
Others
Global Biopharma & Cosmetics market, by Application
Pharmaceuticals, OTC
Cosmetics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma & Cosmetics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharma & Cosmetics
1.1 Biopharma & Cosmetics Market Overview
1.1.1 Biopharma & Cosmetics Product Scope
1.1.2 Biopharma & Cosmetics Market Status and Outlook
1.2 Global Biopharma & Cosmetics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharma & Cosmetics Market Size by Region (2018-2029)
1.4 Global Biopharma & Cosmetics Historic Market Size by Region (2018-2023)
1.5 Global Biopharma & Cosmetics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharma & Cosmetics Market Size (2018-2029)
1.6.1 North America Biopharma & Cosmetics Market Size (2018-2029)
1.6.2 Europe Biopharma & Cosmetics Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharma & Cosmetics Market Size (2018-2029)
1.6.4 Latin America Biopharma & Cosmetics Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharma & Cosmetics Market Size (2018-2029)
2 Biopharma & Cosmetics Market by Type
2.1 Introduction
2.1.1 Ointments
2.1.2 Creams
2.1.3 Gel
2.1.4 Others
2.2 Global Biopharma & Cosmetics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharma & Cosmetics Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharma & Cosmetics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharma & Cosmetics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharma & Cosmetics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharma & Cosmetics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharma & Cosmetics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharma & Cosmetics Revenue Breakdown by Type (2018-2029)
3 Biopharma & Cosmetics Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceuticals, OTC
3.1.2 Cosmetics
3.2 Global Biopharma & Cosmetics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharma & Cosmetics Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharma & Cosmetics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharma & Cosmetics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharma & Cosmetics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharma & Cosmetics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharma & Cosmetics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharma & Cosmetics Revenue Breakdown by Application (2018-2029)
4 Biopharma & Cosmetics Competition Analysis by Players
4.1 Global Biopharma & Cosmetics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharma & Cosmetics as of 2022)
4.3 Date of Key Players Enter into Biopharma & Cosmetics Market
4.4 Global Top Players Biopharma & Cosmetics Headquarters and Area Served
4.5 Key Players Biopharma & Cosmetics Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharma & Cosmetics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Biopharma & Cosmetics Products, Services and Solutions
5.1.4 Johnson & Johnson Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Biopharma & Cosmetics Products, Services and Solutions
5.2.4 Roche Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Biopharma & Cosmetics Products, Services and Solutions
5.3.4 Novartis Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Biopharma & Cosmetics Products, Services and Solutions
5.4.4 Pfizer Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Biopharma & Cosmetics Products, Services and Solutions
5.5.4 Sanofi Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Biopharma & Cosmetics Products, Services and Solutions
5.6.4 Eli Lilly Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 GSK
5.7.1 GSK Profile
5.7.2 GSK Main Business
5.7.3 GSK Biopharma & Cosmetics Products, Services and Solutions
5.7.4 GSK Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.7.5 GSK Recent Developments
5.8 Bayer
5.8.1 Bayer Profile
5.8.2 Bayer Main Business
5.8.3 Bayer Biopharma & Cosmetics Products, Services and Solutions
5.8.4 Bayer Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.8.5 Bayer Recent Developments
5.9 Merck & Co
5.9.1 Merck & Co Profile
5.9.2 Merck & Co Main Business
5.9.3 Merck & Co Biopharma & Cosmetics Products, Services and Solutions
5.9.4 Merck & Co Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.9.5 Merck & Co Recent Developments
5.10 L' OREAL
5.10.1 L' OREAL Profile
5.10.2 L' OREAL Main Business
5.10.3 L' OREAL Biopharma & Cosmetics Products, Services and Solutions
5.10.4 L' OREAL Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.10.5 L' OREAL Recent Developments
5.11 Unilever
5.11.1 Unilever Profile
5.11.2 Unilever Main Business
5.11.3 Unilever Biopharma & Cosmetics Products, Services and Solutions
5.11.4 Unilever Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.11.5 Unilever Recent Developments
5.12 Procter & Gamble
5.12.1 Procter & Gamble Profile
5.12.2 Procter & Gamble Main Business
5.12.3 Procter & Gamble Biopharma & Cosmetics Products, Services and Solutions
5.12.4 Procter & Gamble Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.12.5 Procter & Gamble Recent Developments
5.13 Estee Lauder
5.13.1 Estee Lauder Profile
5.13.2 Estee Lauder Main Business
5.13.3 Estee Lauder Biopharma & Cosmetics Products, Services and Solutions
5.13.4 Estee Lauder Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.13.5 Estee Lauder Recent Developments
5.14 Kao
5.14.1 Kao Profile
5.14.2 Kao Main Business
5.14.3 Kao Biopharma & Cosmetics Products, Services and Solutions
5.14.4 Kao Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.14.5 Kao Recent Developments
5.15 Shiseido
5.15.1 Shiseido Profile
5.15.2 Shiseido Main Business
5.15.3 Shiseido Biopharma & Cosmetics Products, Services and Solutions
5.15.4 Shiseido Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.15.5 Shiseido Recent Developments
5.16 Beiersdorf
5.16.1 Beiersdorf Profile
5.16.2 Beiersdorf Main Business
5.16.3 Beiersdorf Biopharma & Cosmetics Products, Services and Solutions
5.16.4 Beiersdorf Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.16.5 Beiersdorf Recent Developments
5.17 Henkel
5.17.1 Henkel Profile
5.17.2 Henkel Main Business
5.17.3 Henkel Biopharma & Cosmetics Products, Services and Solutions
5.17.4 Henkel Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.17.5 Henkel Recent Developments
5.18 Shanghai Jahwa
5.18.1 Shanghai Jahwa Profile
5.18.2 Shanghai Jahwa Main Business
5.18.3 Shanghai Jahwa Biopharma & Cosmetics Products, Services and Solutions
5.18.4 Shanghai Jahwa Biopharma & Cosmetics Revenue (US$ Million) & (2018-2023)
5.18.5 Shanghai Jahwa Recent Developments
6 North America
6.1 North America Biopharma & Cosmetics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biopharma & Cosmetics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharma & Cosmetics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharma & Cosmetics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharma & Cosmetics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharma & Cosmetics Market Dynamics
11.1 Biopharma & Cosmetics Industry Trends
11.2 Biopharma & Cosmetics Market Drivers
11.3 Biopharma & Cosmetics Market Challenges
11.4 Biopharma & Cosmetics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
